C WorldWide Group’s bluebird bio BLUE Stock Holding History

C WorldWide Group’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-184	Closed	-$236K	–	116
2018 Q4	$236K	Sell	184 -5	-3%	-$7.67K	﹤0.01%	116
2018 Q3	$357K	Buy	189 +27	+17%	+$55.8K	﹤0.01%	120
2018 Q2	$329K	Hold	162	–	–	﹤0.01%	118
2018 Q1	$358K	Sell	162 -5	-3%	-$12.7K	0.01%	114
2017 Q4	$385K	Sell	167 -24	-13%	-$48.7K	0.01%	111
2017 Q3	$340K	Buy	191 +29	+18%	+$40.5K	﹤0.01%	116
2017 Q2	$221K	Sell	162 -28	-15%	-$33.8K	﹤0.01%	119
2017 Q1	$223K	Sell	190 -59	-24%	-$60.2K	﹤0.01%	118
2016 Q4	$199K	Sell	249 -369	-60%	-$293K	﹤0.01%	116
2016 Q3	$542K	Buy	618 +124	+25%	+$89.8K	0.01%	121
2016 Q2	$277K	Buy	494 +108	+28%	+$61.2K	0.01%	110
2016 Q1	$212K	Hold	386	–	–	﹤0.01%	121
2015 Q4	$321K	Buy	+386	New	+$386K	0.01%	128

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

C WorldWide Group's BLUE Position: Q1 2019 in Review

C WorldWide Group sold out of bluebird bio (BLUE) in Q1 2019, closing a stake of 184 shares — an estimated $236K sold.

C WorldWide Group first reported a position in BLUE in Q4 2015 and held it in 13 quarters. The position peaked at $542K in Q3 2016. 288 funds tracked by Wall St. Rank hold BLUE as of Q1 2019.

C WorldWide Group reported no remaining bluebird bio position as of Q1 2019 after selling out during the quarter.
C WorldWide Group sold 184 bluebird bio shares in Q1 2019, an estimated $236K.
C WorldWide Group first reported a position in bluebird bio in Q4 2015 and held it in 13 quarters.
C WorldWide Group's bluebird bio position peaked at $542K in Q3 2016.
288 funds tracked by Wall St. Rank held bluebird bio as of Q1 2019.

Based on C WorldWide Group's 13F filing for Q1 2019, filed 3 May 2019.